Prescription Digital Therapeutics (PDTs) are software applications that deliver evidence-based therapeutic interventions to patients to prevent or treat a medical disorder or disease. They are used independently or in concert with medications or other therapies to optimize patient care and health outcomes.
According to the Digital Therapeutics Alliance , PDTs incorporate advanced technology best practices relating to design, clinical validation, usability, and data security. They are validated by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use. Digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.
Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. Digital therapeutics are distinguished from other digital health categories through their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease.
Access Market Intelligence’s inaugural Digital Therapeutics Insight line focuses on PDTs in the commercial insurance market. Our service includes an industry database, landscape and trend reports, custom research, and strategy consulting with an emphasis on market access and reimbursement. Previously published reports in this series include:
- Digital Therapeutics in the Diabetes Market
- Digital Therapeutics in the Behavioral Health Market
- Direct to Consumer Pharmacies Overview
- Digital Therapeutics in the CNS Market
- Digital Therapeutics in the Oncology Market
|Application||Type||DTx Company||Partners||End User||Reimbursement|
AMI’s new report: Digital Therapeutics in the Gastroenterology Market, provides a brief overview of the Gastroenterology market and profiles the digital therapeutic companies offering products and services. Company profiles include: address, website, executive contacts, background, products, partners, and recent activities.
The Table of Contents include:
Digital Therapeutics Introduction – pgs. 4-5
Gastroenterology Overview – pgs. 6-8
Digital Therapeutic Company Profiles – pgs. 9-44
- Astarte Medical – pgs. 11-12
- Atmo Biosciences – pgs. 13-14
- Betr Health – pg. 15
- Bold Health – pgs. 16-17
- Cara Care – pgs. 18-19
- DayTwo Inc. – pgs. 20-21
- Digbi Health – pgs. 22-23
- FoodMarble – pg. 24
- Gelesis, Inc. – pgs. 25-27
- KORE Digital Health Therapeutics – pgs. 28-30
- metaMe Health – pgs. 31-32
- MyGiHealth – pgs. 33-34
- Oshi Health – pgs. 35-36
- Pear Therapeutics – pgs. 37-40
- Health – pgs. 41-43
- Vivante Health – pg. 44
- References/Sources – pg. 45